vimarsana.com

Latest Breaking News On - Keith vendola - Page 1 : vimarsana.com

Wugen Strengthens Executive Leadership Team with Appointment of Keith Vendola, M D , M B A as Chief Financial Officer

ST. LOUIS and SAN DIEGO, Jan. 03, 2024 (GLOBE NEWSWIRE) Wugen, Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell…

IO Biotech Hosting Key Opinion Leader Webinar Series

IO Biotech Announces Presentation of New Data from MM1636 Phase 1/2 Clinical Trial Presented at 2022 AACR Annual Meeting

IO Biotech to Present at 42nd Annual Cowen Healthcare Conference

IO Biotech to Present at 42nd Annual Cowen Healthcare Conference
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

01 29 21 -- How To Establish An Effective CRO Partnership

01.29.21 How To Establish An Effective CRO Partnership   Continuing our Cell & Gene Series, Business of Biotech features Dr. Bobby Gaspar, Orchard Therapeutics CEO, speaking on the challenges his company faces in the production of hematopoietic stem cells to treat neurometabolic disorders, primary immune deficiencies, and blood disorders. Listen now and subscribe so you never miss an episode. Video Josh Brumm, CEO of Dyne Therapeutics, discusses some of the “pros” to pitching virtually. Keith Vendola, M.D., CSO, and head of strategy at Rezolute, adds to the conversation by discussing the difficulty of making a human connection via Zoom. This is a segment of a larger executive virtual roundtable (EVR) that also included Markus Warmuth, M.D., CEO, of Monte Rosa Therapeutics, on the topic of “Pitching and Fundraising in the New Norm.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.